Celltrion to Speed Up for the development of Coronvirus Treatment
Celltrion to Speed Up for the development of Coronvirus Treatment
  • Kim Min-jee
  • 승인 2020.03.20 06:00
  • 댓글 0
이 기사를 공유합니다

Celltrion Group Chairman Seo Jung-jin

Celltrion said on March 19 that it has completed the establishment of a cooperative system with the Korea Centers for Disease Control and Prevention (KCDC), further speeding up the development of the treatment.

Celltrion has recently been selected as the preferred bidder for a state-run project to develop the Coronavirus (COVID-19) treatment, which was announced by the KCDC.

The company plans to work closely with the KCDC to put all of the company's capabilities into developing COVID-19 treatments that are spreading around the world. It has been focusing on developing COVID-19 therapeutic antibodies with the experience of developing new influenza multi-irritant drugs and antibodies to treat MERS (Middle East Respiratory Syndrome).

Celltrion recently received blood from a South Korean medical institution for COVID-19-recovered patients and has started to excavate candidate materials for new drugs to develop antibodies. Once it completes the development of antibody substances within six months, it plans to begin clinical trials immediately.

In an online press conference on March 12, Celltrion Group Chairman Seo Jung-jin said, "We will actively cooperate with government agencies so that the situation can end without further delay by striving to develop COVID-19 therapeutic antibodies."

Meanwhile, Celltrion will soon hold its second online press conference and announce progress in the development of COVID-19 treatments.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: www.koreaittimes.com / m.koreaittimes.com. Editorial Div. 02-578-0434 / 010-2442-9446. Email: info@koreaittimes.com.
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.
ND소프트